Related Experiment Video
Updated: Jan 15, 2026
03:40
Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
1.3K
A REDCap advanced randomization module to meet the needs of modern trials
Luke Stevens1, Nan Kennedy2, Rob J Taylor2
1Murdoch Children's Research Institute, The Royal Children's Hospital, Parkville, Victoria, Australia; Clinical Epidemiology and Biostatistics Unit, Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia.
Journal of Biomedical Informatics
|October 6, 2025
Summary
A new REDCap randomization module enhances clinical trials by supporting complex designs like adaptive and decentralized trials. This advanced tool streamlines randomization, improving efficiency and data integrity for sophisticated research.
Area of Science:
- Clinical Trials Methodology
- Biostatistics
- Health Informatics
Background:
- The REDCap electronic data capture platform previously offered a basic randomization module suitable for single randomizations.
- Modern clinical trial designs, including adaptive, decentralized, and pragmatic trials, require more advanced randomization capabilities not supported by the original module.
- These advanced designs necessitate features like multiple randomizations, adaptive allocation, and flexible group management.
Purpose of the Study:
- To develop and implement advanced randomization functions within the REDCap platform.
- To address the limitations of the existing REDCap randomization module for complex trial designs.
- To enhance the capabilities of REDCap for conducting sophisticated clinical trials.
Main Methods:
- A collaborative development process involving clinical trialists, biostatisticians, and technologists.
- Modernization of the REDCap randomization module facilitated by the NIH-funded Trial Innovation Network.
- Incorporation of expert feedback to guide the development of new randomization features.
Main Results:
- Development of an advanced REDCap randomization module supporting platform, adaptive, decentralized, and pragmatic trials.
- Introduction of features such as improved blinded randomization support, enhanced metadata capture (user identity, timestamp), and administrative tools.
- Enabling randomization via surveys for pragmatic/decentralized trials without login access.
- Significant adoption with multiple randomizations used in 211 projects, real-time trigger logic in 108 projects, and blinded group allocation in 24 projects by June 2025.
Conclusions:
- The enhanced REDCap randomization module supports more sophisticated and adaptive clinical trial designs.
- The new module streamlines the randomization process, leading to improved trial efficiency.
- Robust data integrity is ensured, facilitating advanced clinical research methodologies.
Keywords:
Adaptive trialsDecentralized trialsMulti-stage randomizationPlatform trialsREDCapRandomization moduleSMART trialsMore Related Videos
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
15.0K
04:58Reduced Procedure Time and Variability with Active Esophageal Cooling During Radiofrequency Ablation for Atrial Fibrillation
Published on: August 25, 2022
2.5K
Related Concept Videos
01:13Randomized Experiments
8.8K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
8.8K
01:11Blinding
3.8K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
3.8K
01:11Clinical Trials: Overview
4.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.6K
01:20Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
226
Body:Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to...
226
02:01Group Design
10.2K
The most basic experimental design involves two groups: the experimental group and the control group. The two groups are designed to be the same except for one difference— experimental manipulation. The experimental group gets the experimental manipulation—that is, the treatment or variable being tested—and the control group does not. Since experimental manipulation is the only difference between the experimental and control groups, we can be sure that any differences between...
10.2K
01:16Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K